Nan Ji
Company: PAQ Therapeutics
Job title: CEO
Seminars:
Examining Proof of Concept (PoC) Studies of Catalytic, Proximityinduced, Autophagy-dependent Degradation of Proteins & NonProtei 3:30 pm
Comparing and contrasting the ubiquitin-proteosome system vs autophagy-lysosome system Studying the PoC studies of proximity-induced, autophagy-dependent degradation Elucidating the potential of autophagy-based, targeted degradationRead more
day: Conference Day Two
PANEL DISCUSSION: Tackling the Unique Challenges that Novel Proximity Approaches Face for Efficient Drug Development 10:00 am
Addressing the differences between targeted protein degradation and other modalities, along with the challenges that arise from this, such as: What are the benchmarking standards when creating new protein species to test the efficacy of your drugs? How to address the reversibility of post-translational modifications for sustained therapeutic effect? Increasing the bio-chemical and bio-physical understanding…Read more
day: Conference Day Two